Third-generation cephalosporin resistant gram-negative bacteraemia in patients with haematological malignancy; an 11-year multi-centre retrospective study

Autor: de la Court, Jara R., Woudt, Sjoukje H. S., Schoffelen, Annelot F., Heijmans, Jarom, de Jonge, Nick A., van der Bruggen, Tjomme, Bomers, Marije K., Lambregts, Merel M. C., Schade, Rogier P., Sigaloff, Kim C. E., Stuart, J. W. T. Cohen, Melles, D. C., van Dijk, K., Alzubaidy, A., Werdmuller, B. F. M., Blaauw, G. J., Diederen, B. M. W., Alblas, H. J., der Kuil, W. Altorf-van, Bierman, S. M., de Greeff, S. C., Groenendijk, S. R., Hertroys, R., Kuijper, E. J., Monen, J. C., Notermans, D. W., van den Reek, W. J., Smilde, A. E., Wielders, C. C. H., Zoetigheid, R. E., van den Bijllaardt, W., Kraan, E. M., Mattsson, E. E., da Silva, J. M., de Jong, E., Maraha, B., van Asselt, G. J., Demeulemeester, A., Wintermans, B. B., van Trijp, M., Ott, A., Sinnige, J., Silvis, W., Bakker, L. J., Dorigo-Zetsma, J. W., Waar, K., Bernards, A. T., Hall, M. A. Leversteijn-van, Schaftenaar, E., Nabuurs-Franssen, M. H., Wertheim, H., Bode, L., van Rijn, M., Dinant, S., Pontesilli, O., de Man, P., Wong, M., Muller, A. E., Renders, N. H., Bentvelsen, R. G., Buiting, A. G. M., Vlek, A. L. M., Stam, A. J., Troelstra, A., Overdevest, I. T. M. A., van Meer, M. P. A., dos Santos, C. Oliveira, Wolfhagen, M. J. H. M.

Publikováno v: ISIS-AR study group 2022, ' Third-generation cephalosporin resistant gram-negative bacteraemia in patients with haematological malignancy; an 11-year multi-centre retrospective study ', Annals of Clinical Microbiology and Antimicrobials, vol. 21, no. 1, 54 . https://doi.org/10.1186/s12941-022-00544-0
Annals of Clinical Microbiology and Antimicrobials, 21(1):54. BioMed Central Ltd.
Annals of clinical microbiology and antimicrobials, 21(1):54. BioMed Central
Annals of Clinical Microbiology and Antimicrobials, 21(1). BMC

Objectives Among patients with haematological malignancy, bacteraemia is a common complication during chemotherapy-induced neutropenia. Resistance of gram-negative bacteria (GNB) to third-generation cephalosporins (3GC) is increasing. In order to exp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::090e11b56efc1a6cc928f4770cb8377c
https://doi.org/10.1186/s12941-022-00544-0

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Propofol and thiopental for refractory status epilepticus in children

Autor: Gestel, J P.J. van, Oud-Alblas, H J. Blussé van, Malingré, M, Ververs, F F.T., Braun, K P.J., van Nieuwenhuizen, O

Publikováno v: Neurology (Ovid); August 2005, Vol. 65 Issue: 4 p591-592, 2p

An integrated population pharmacokinetic meta-analysis of propofol in morbidly obese and nonobese adults, adolescents, and children.

Autor: Diepstraten J; Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands., Chidambaran V, Sadhasivam S, Blussé van Oud-Alblas HJ, Inge T, van Ramshorst B, van Dongen EP, Vinks AA, Knibbe CA

Publikováno v: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2013 Sep 11; Vol. 2, pp. e73. Date of Electronic Publication: 2013 Sep 11.

Propofol and thiopental for refractory status epilepticus in children.

Autor: van Gestel JP; Pediatric Intensive Care Unit, University Medical Center Utrecht, Wilhelmina Children's Hospital, The Netherlands. j.vangestel@umcutrecht.nl, Blussé van Oud-Alblas HJ, Malingré M, Ververs FF, Braun KP, van Nieuwenhuizen O

Publikováno v: Neurology [Neurology] 2005 Aug 23; Vol. 65 (4), pp. 591-2.